The "Brazil Pet Veterinary Drugs Market Analysis & Opportunity Outlook 2024" report has been added to ResearchAndMarkets.com's offering.
Rising incidences of infections and diseases in pet animals are the major factors behind the growth of pet veterinary drugs market. Further, pet diseases and infections have the risk of being transmitted to humans. This factor is spurring the demand for pet veterinary drugs as associated infections and diseases can be life-threatening. Moreover, the infection rate among pet animals has been continuously increasing. This is expected to increase the demand for the antibacterial and anti-parasitic veterinary drugs in the upcoming years.
Furthermore, the trend of adoption of pets is increasing the risk of diseases transmitted to humans by animals. Rising government regulations to protect humans from animal transferable disease are opening the opportunities for the pet pharmaceutical drugs manufacturers to develop and introduce various products to control the disease.
In addition to this, defined standards by the government healthcare agencies ensure the quality, safety and efficacy of animal health care products and to prevent the penetration of substandard veterinary drugs in the market. This factor is increasing the market revenue of organized players and encouraging them to develop and launch new and innovative animal healthcare products.
Key Players
- Bayer Animal Health
- Ceva Animal Healthcare
- Elanco Animal Health
- Merck Ltd.
- Zoetis Animal Healthcare
- Virbac do Brasil Industria e Comercio Ltda
- Merial Animal Health
- Vetnil
- UCBVET
- J.A. Animal Health
Market Segmentation
By Oral Drugs
- Drugs
- Vaccines
- Inactivated Vaccines
- Attenuated Vaccines
- Recombinant Vaccines
- Feed Additives
- Amino Acids
- Antibiotics
By Conditions
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
By Route of Administration
- Oral
- Parenteral
- Topical
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Drug Stores
Key Topics Covered
1. Executive Summary
2. Research Methodology
3. Risk Analysis
4. Brazil Pet Veterinary Drugs Market Size (USD Million) and Forecast, 2016-2024
5. Market Dynamics & Its Impact Analysis
6. Brazil Market Segmentation Analysis
7. Porter's Five Force Model Analysis
8. Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/research/qsrls9/brazil_pet?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180321005650/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Animal
Healthcare/Veterinary, Animal
Pharmaceuticals